Sirolimus Therapy Predisposes to New-Onset Diabetes Mellitus After Renal Transplantation: A Long-Term Analysis of Various Treatment Regimens von Gyurus, E, Kaposztas, Z, Kahan, B.D

Volltext

Impact of rituximab therapy for treatment of acute humoral rejection von Kaposztas, Z., Podder, H., Mauiyyedi, S., Illoh, O., Kerman, R., Reyes, M., Pollard, V., Kahan, B.D.

Volltext

THE RUBY ANNIVERSARY von Kahan, B.D

Volltext

Fifty Years in the Vineyard of Transplantation: Looking Back von Kahan, B.D

Volltext

Fifteen Years of Clinical Studies and Clinical Practice in Renal Transplantation: Reviewing Outcomes With De Novo Use of Sirolimus in Combination With Cyclosporine von Kahan, B.D

Volltext

New-Onset Diabetes After Renal Transplantation: Diagnosis, Incidence, Risk Factors, Impact on Outcomes, and Novel Implications von Kaposztas, Z, Gyurus, E, Kahan, B.D

Volltext

Better Actual 10-Year Renal Transplant Outcomes of 80% Reduced Cyclosporine Exposure With Sirolimus Base Therapy Compared With Full Cyclosporine Exposure Without or With Concomitta... von Pliszczynski, J, Kahan, B.D

Volltext

Frontiers in Immunosuppression von Kahan, B.D

Volltext

Therapeutic drug monitoring of cyclosporine: 20 years of progress von Kahan, B.D

Volltext

Forty Years of Publication of Transplantation Proceedings —The Third Decade : The Expansion of the Enterprise von Kahan, B.D

Volltext

Current Approaches to the Use of Sirolimus In Renal Transplantation von Kahan, B.D

Volltext

Bortezomib Successfully Reverses Early Recurrence of Light-Chain Deposition Disease in a Renal Allograft: A Case Report von Kaposztas, Z, Kahan, B.D, Katz, S.M, Van Buren, C.T, Cherem, L

Volltext

Statins Benefit Outcomes of Renal Transplant Recipients on a Sirolimus-Cyclosporine Regimen von Lisik, W, Schoenberg, L, Lasky, R.E, Kahan, B.D

Volltext

Frontiers in Immunosuppression von Kahan, B.D

Volltext

Case Report: Successful Treatment of Posttransplant Lymphoproliferative Disorder and Quiescence of Dermatomyositis With Rituximab and Sirolimus von Kaposztas, Z, Etheridge, W.B, Kahan, B.D

Volltext

FTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one-yr multicenter study von Tedesco-Silva, H., Lorber, M.I., Foster, C.E., Sollinger, H.W., Mendez, R., Carvalho, D.B., Shapiro, R., Rajagopalan, P.R., Mayer, H., Slade, J., Kahan, B.D.

Volltext

The Impact of Conversion From Mycophenolate Mofetil to Mycophenolate Sodium Among Renal Transplant Recipients on a Sirolimus-Based Regimen von Kahan, B.D, Podbielski, J, Childs, B

Volltext

Forty Years of Publication of Transplantation Proceedings—The Third Decade ⁎ ⁎ This is the third in the series Ruby Anniversary. The previous publications are: The Ruby Anniversary... von Kahan, B.D.

Volltext

Two-year results of multicenter phase III trials on the effect of the addition of sirolimus to Cyclosporine-based immunosuppressive regimens in renal transplantation von Kahan, B.D

Volltext

The place of sirolimus in kidney transplantation: Can we reduce calcineurin inhibitor renal toxicity? von Knight, R.J., Kahan, B.D.

Volltext